CSI Market
Sign In | Register

Pfizer Inc (PFE) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access PFE Annual Income Statement →
From Pfizer Inc through Jun 29 2025, changes in Jun 28 2026's revenue and cost structure provide insight into profitability trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 28 2026)
Q2 2026 		(Mar 29 2026) (Dec 31 2025) (Sep 28 2025) (Jun 29 2025)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax0.00
Total Revenue15,034.00
Costs & Expenses
Cost of Goods and Services Sold4,092.00
Gross Profit10,942.00
Selling, Administration, Marketing3,411.00
Depreciation & Amortization1,622.00
Research & Development2,825.00
Restructuring Charges AndAcquisition Related Costs3,940.00
Total operating costs including COS0.00
Operating income / -loss0.00
Net Interest Expense / -Income0.00
Loss/ -Gain on Investment113.00
Other loss/ -income0.00
Total costs & expenses15,687.00
Income & Taxes
Income / -loss before income taxes-653.00
Income taxes expenses / -benefit-407.00
Income after income taxes-246.00
Net income / -loss of other equity0.00
Income / -loss from continuing operations-246.00
Discontinued operations8.00
Non-controlling interests10.00
Net income / -loss-237.00
Income / -loss to shareholder-248.00
EBIT-653.00
EBITD969.00
EBITDA969.00
Earnings Per Share
Basic EPS (excl. extra items)-0.04
Extraordinary items0.00
Basic Net EPS-0.04
Basic shares outstanding (Mill. of Units)5,699.00
Diluted Net EPS-0.04
Diluted average shares (Mill. of Units)5,699.00
Dividend per share0.86
4 historic quarters locked

Sign in to unlock the full Pfizer Inc income statement history.

Sign In Create Free Account

About Pfizer Inc Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: August 4, 2026
  • Original filing: pfe-20260628.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.